Biosimilar Newsletter Archive

1. 05.07.21 -- 4 Tips To Navigating The Biopharma Fast Lane 5/7/2021
   05/07/21 Biosimilar Development Newsletter
2. 05.06.21 -- No, Biologics Are Not Natural Monopolies 5/6/2021
   05/06/21 Biosimilar Development Newsletter
3. 05.03.21 -- Considerations For A Successful Process Development 5/3/2021
   05/03/21 Biosimilar Development Newsletter
4. 04.29.21 -- Making Sense Of Antibody Epitope Claims 4/29/2021
   04/29/21 Biosimilar Development Newsletter
5. 04.23.21 -- Make Buffer Management And Chromatography Your Competitive Advantages 4/23/2021
   04/23/21 Biosimilar Development Newsletter
6. 04.22.21 -- Interacting With FDA During Biosimilar Development 4/22/2021
   04/22/21 Biosimilar Development Newsletter
7. 04.19.21 -- Cell & Gene Therapy Process Development Resources 4/19/2021
   04/19/21 Biosimilar Development Newsletter
8. 04.15.21 -- The Biosimilar Leadership Playbook: 5 Tips For Success 4/15/2021
   04/15/21 Biosimilar Development Newsletter
9. 04.14.21 -- Accelerate Viral Detection From Weeks To Days 4/14/2021
   04/14/21 Biosimilar Development Newsletter
10. 04.11.21 -- Biosimilar Education Across Europe: The Right Message 4/11/2021
    04/11/21 Biosimilar Development Newsletter